Clinical Trial Status: Where Each Compound Stands in 2026 Tirzepatide (Fully Approved) Tirzepatide completed its regulatory journey and received: FDA approval as Mounjaro (2022) for type 2 diabetes management FDA approval as Zepbound (2023) for chronic weight management in adults with obesity or overweight with weight-related comorbidities It is available via prescription from licensed healthcare providers in the United States and many other countries
I tested positive for A1298C only
Semaglutide is a medical prescription used for managing weight loss
Common side effects include: Nausea and vomiting Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite (which, whilst an intended effect, can occasionally be excessive) Belching or indigestion Most of these effects are mild to moderate in severity and transient
GLP-1 Activators are natural methods or supplements that help increase GLP-1 naturally , supporting better appetite control and energy regulation
A licensed New York healthcare provider will review your medical history, medications, wellness goals, treatment eligibility and available self-pay programs